Bjureberg Johan, Dahlin Marie, Carlborg Andreas, Edberg Hanna, Haglund Axel, Runeson Bo
Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Department of Psychology, Stanford University, Stanford, California, USA.
Psychol Med. 2021 Mar 26;52(16):1-9. doi: 10.1017/S0033291721000751.
Suicide screening is routine practice in psychiatric emergency (PE) departments, but evidence for screening instruments is sparse. Improved identification of nascent suicide risk is important for suicide prevention. The aim of the current study was to evaluate the association between the novel Colombia Suicide Severity Rating Scale Screen Version (C-SSRS Screen) and subsequent clinical management and suicide within 1 week, 1 month and 1 year from screening.
Consecutive patients (N = 18 684) attending a PE department in Stockholm, Sweden between 1 May 2016 and 31 December 2017 were assessed with the C-SSRS Screen. All patients (52.1% women; mean age = 39.7, s.d. = 16.9) were followed-up in the National Cause of Death Register. Logistic regression and receiver operating characteristic curves analyses were conducted. Optimal cut-offs and accuracy statistics were calculated.
Both suicidal ideation and behaviour were prevalent at screening. In total, 107 patients died by suicide during follow-up. Both C-SSRS Screen Ideation Severity and Behaviour Scales were associated with death by suicide within 1-week, 1-month and 1-year follow-up. The optimal cut-off for the ideation severity scale was associated with at least four times the odds of dying by suicide within 1 week (adjusted OR 4.7, 95% confidence interval 1.5-14.8). Both scales were also associated with short-term clinical management.
The C-SSRS Screen may be feasible to use in the actual management setting as an initial step before the clinical assessment of suicide risk. Future research may investigate the utility of combining the C-SSRS Screen with a more thorough assessment.
自杀筛查是精神科急诊(PE)科室的常规做法,但筛查工具的证据稀少。更好地识别初现的自杀风险对于预防自杀很重要。本研究的目的是评估新型哥伦比亚自杀严重程度评定量表筛查版(C-SSRS Screen)与筛查后1周、1个月和1年内的后续临床管理及自杀之间的关联。
对2016年5月1日至2017年12月31日期间在瑞典斯德哥尔摩一家PE科室就诊的连续患者(N = 18684)使用C-SSRS Screen进行评估。所有患者(52.1%为女性;平均年龄 = 39.7,标准差 = 16.9)在国家死亡原因登记处进行随访。进行了逻辑回归和受试者工作特征曲线分析。计算了最佳截断值和准确性统计数据。
筛查时自杀意念和行为都很普遍。随访期间共有107名患者自杀死亡。C-SSRS Screen意念严重程度量表和行为量表均与1周、1个月和1年随访期间的自杀死亡相关。意念严重程度量表的最佳截断值与1周内自杀死亡几率至少高出四倍相关(调整后的比值比为4.7,95%置信区间为1.5 - 14.8)。两个量表也都与短期临床管理相关。
C-SSRS Screen在实际管理环境中作为自杀风险临床评估前的初步步骤可能是可行的。未来的研究可以调查将C-SSRS Screen与更全面评估相结合的效用。